Skip to main content
OpenTrials
Completed

NCT Number: NCT05854420

Modified Anterior Lamellar Recession for All Grades of Upper Eyelid Trachomatous Cicatricial Entropion

This study aims to assess the combination of anterior lamellar recession (ALR) with blepharoplasty, suprasternal fixation, and internal eyelash bulb extirpation of aberrant lashes posteriorly located in patients with any grade of upper eyelid trachomatous cicatricial entropion

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Entropion Eye Diseases Eyelid Diseases

Age range

45 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ehab tharwat

Damietta, New Damietta, 34517, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients presented with upper lid trachomatous cicatricial entropion associated with rubbing lashes.
  • Patients having a history of argon laser ablation, electrolysis, epilation, or past unsuccessful surgery were also included

Exclusion criteria

  • Patients with a follow-up period of fewer than 12 months.
  • Patients with very severe UCE and required posterior lamellar grafts.
  • Patients with etiology other than trachoma.
  • Patients with dysplastic lashes without entropion were excluded

Treatment and study plan

Modified anterior Lamellar Recession

Procedure

ALR is one of the procedures used to treat cicatricial entropion and trichiasis. Few studies present the effect of modifications to this procedure in trachomatous entropion and trichiasis. Because trachoma is common in our country, there is a probability that the number of surgeries for TT will rise.

Primary outcomes

  1. Success rate

    Time frame: 3 months post operative

    The cases will be considered succeed if there is no recurrence of the entropion

  2. Success rate

    Time frame: 6 months post operative

    The cases will be considered succeed if there is no recurrence of the entropion

  3. Success rate

    Time frame: 9 months post operative

    The cases will be considered succeed if there is no recurrence of the entropion

  4. Success rate

    Time frame: 12 months post operative

    The cases will be considered succeed if there is no recurrence of the entropion

Sponsors and collaborators

Lead sponsor

Al-Azhar University

Other

Registry information

Important dates

Study start
2018
Primary completion
2021
Study completion
2021
First posted
May 11, 2023
Registry last updated
May 11, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.